ReviewDiabetes therapy : research, treatment and education of diabetes and related disorders2026
Pen Needle Reuse in People with Diabetes Who Inject Insulin: A Narrative Review.
Review in Diabetes therapy : research, treatment and education of diabetes and related disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionGlobal rates of insulin pen needle (PN) reuse in people with diabetes (PWD) vary across regions. However, it is estimated that more than 50% of PWD will reuse their PNs at some point over the course of their disease management. This highlights the need for better education to avoid this practice, which can lead to complications such as lipohypertrophy, pain, and poor glycemic management. This review aims to educate healthcare professionals (HCPs) on the issues surrounding PN reuse by PWD; discuss the scientific and clinical rationale for and against PN reuse; provide guidance on best practice for PN use by PWD who use insulin when reuse continues or is unavoidable; and provide actionable insights for clinical education and person-centered support interventions.
methodsTo compile the data on PN reuse, a PubMed search was conducted in November 2025, with "diabetes", "insulin", and "needle reuse" as the search terms. Over 100 articles were found and assessed for inclusion based on scientific vigor, leaving approximately 40 articles for inclusion.
resultsThe main reasons for PN reuse were stated to be convenience and cost in many regions around the world.
conclusionsThe findings of this review suggest that reducing PN reuse rates requires continued, ongoing education about injection technique and potential complications of PN reuse. Ideally, this education should be provided by HCPs and diabetes educators, as they are the most trusted source of information for PWD. It is vital to determine the reasons for reuse without judgment and discuss suitable solutions to mitigate the problem.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.